You have 9 free searches left this month | for more free features.

Myelodysplasia

Showing 1 - 25 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refine and Assess Readability of Patient, Carer, and Clinician

Completed
  • Myelodysplastic Syndrome (MDS)
  • Carer Treatment Preference Myelodysplasia Questionnaire
  • +2 more
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
Apr 4, 2023

Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • MGTA-117
  • Duarte, California
  • +7 more
Nov 23, 2022

Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

Recruiting
  • Myelodysplasia
  • Hematologic Malignancy
  • CliniMACS® TCRαβ/CD19 Combined Depletion System
  • Columbus, Ohio
    Nationwide Children's Hospital
Jan 11, 2022

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023

High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Hematological Malignancy
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Seattle, Washington
    Fred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Stockholm, Sweden
    Department of Hematology, Karolinska University Hospital
Mar 27, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)

Recruiting
  • Acute Myeloid Leukaemia
  • Myelodysplasia
  • Birmingham, United Kingdom
    Queen Elizabeth Hospital
Oct 14, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

Recruiting
  • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
  • Duarte, California
  • +12 more
Jan 4, 2023

Myelodysplasia, Leukemia Trial in Providence (chemo)

Terminated
  • Myelodysplasia
  • Leukemia
  • Providence, Rhode Island
    Lifespan Hospitals
Jan 5, 2022

High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

Recruiting
  • High Risk Hematologic Malignancy
  • Cord Blood Transplant
  • Transplant with an expanded ECT-001 cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)

Recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
  • Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
  • Atlanta, Georgia
  • +2 more
Jul 15, 2022

Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)

Active, not recruiting
  • Hodgkin Lymphoma
  • +6 more
  • Intravenous (IV) and oral Vitamin C
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))

Recruiting
  • Multiple Myeloma
  • +13 more
  • RITA (App)
  • Milano, Italy
    ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022

Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Haplo SCT with NK cells
  • Haplo SCT
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021

Aml, AML, Adult Trial (Nivolumab, Azacitidine)

Withdrawn
  • Aml
  • AML, Adult
  • (no location specified)
Oct 9, 2020

Thrombocytopenia, Immune Thrombocytopenia, Myelodysplasia Trial in Pessac (Blood samples)

Recruiting
  • Thrombocytopenia
  • +2 more
  • Blood samples
  • Pessac, France
    CHU de Bordeaux - service de médecine interne
May 27, 2021